PMU37 Influence of Patient Population & HTA Assessment on Price Erosion Due to Indication Expansion in Europe: Evaluation across Oncology & NON-Oncology Biopharmaceutical Innovations.

2021 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []